Stockreport

Simulations Plus: Buying On Long-Term Silico Drug-Development [Seeking Alpha]

Simulations Plus, Inc.  (SLP) 
Last simulations plus, inc. earnings: 4/9 04:35 pm Check Earnings Report
US:NASDAQ Investor Relations: simulations-plus.com/software/overview
PDF SLP's services help across discovery, development, and clinical operations. Software remains their main economic driver with higher margins. Services are growing fast [Read more]